Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis.

Antar SA, Mensah E, Dahlka J, Renton MC, Raslan AA, Aziz M, Halouani A, Imani S, Parashar A, Johnstone SR, Benezra R, Fraidenraich D, Ligresti G, Sassi Y

Open source

DOI
10.7150/thno.127118
Published
2026
Container
Theranostics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7150/thno.127118,
  title = {Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis.},
  author = {Antar SA and Mensah E and Dahlka J and Renton MC and Raslan AA and Aziz M and Halouani A and Imani S and Parashar A and Johnstone SR and Benezra R and Fraidenraich D and Ligresti G and Sassi Y},
  year = {2026},
  journal = {Theranostics},
  doi = {10.7150/thno.127118},
  url = {https://doi.org/10.7150/thno.127118}
}

RIS

TY  - JOUR
TI  - Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis.
AU  - Antar SA
AU  - Mensah E
AU  - Dahlka J
AU  - Renton MC
AU  - Raslan AA
AU  - Aziz M
AU  - Halouani A
AU  - Imani S
AU  - Parashar A
AU  - Johnstone SR
AU  - Benezra R
AU  - Fraidenraich D
AU  - Ligresti G
AU  - Sassi Y
PY  - 2026
JO  - Theranostics
DO  - 10.7150/thno.127118
UR  - https://doi.org/10.7150/thno.127118
ER  - 

APA

SA, A., E, M., J, D., MC, R., AA, R., M, A., A, H., S, I., A, P., SR, J., R, B., D, F., G, L., & Y, S. (2026). Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis.. Theranostics. https://doi.org/10.7150/thno.127118

Source records